256 related articles for article (PubMed ID: 27023116)
1. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
[TBL] [Abstract][Full Text] [Related]
2. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system.
Shen LJ; Wang SY; Xie GF; Zeng Q; Chen C; Dong AN; Huang ZM; Pan CC; Xia YF; Wu PH
Chin J Cancer; 2015 Aug; 34(10):450-8. PubMed ID: 26264052
[TBL] [Abstract][Full Text] [Related]
3. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.
Shen L; Dong J; Li S; Wang Y; Dong A; Shu W; Wu M; Pan C; Xia Y; Wu P
Oncologist; 2015 Mar; 20(3):291-8. PubMed ID: 25660157
[TBL] [Abstract][Full Text] [Related]
4. Establishing subdivisions of M1 stage nasopharyngeal carcinoma based on decision tree classification: A multicenter retrospective study.
Liu Y; Zuo ZC; Zeng XY; Ma J; Ma CX; Chen RZ; Liang ZG; Chen KH; Li L; Qu S; Lu JY; Zhu XD
Oral Oncol; 2024 Jun; 153():106834. PubMed ID: 38718458
[TBL] [Abstract][Full Text] [Related]
5. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment.
Zou X; You R; Liu H; He YX; Xie GF; Xie ZH; Li JB; Jiang R; Liu LZ; Li L; Zhang MX; Liu YP; Hua YJ; Guo L; Qian CN; Mai HQ; Chen DP; Luo Y; Shen LF; Hong MH; Chen MY
Eur J Cancer; 2017 May; 77():117-126. PubMed ID: 28391025
[TBL] [Abstract][Full Text] [Related]
6. Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas.
Lin M; Yang Q; You R; Zou X; Duan CY; Liu YP; Huang PY; Xie YL; Wang ZQ; Liu T; Chen SY; Hua YJ; Chen MY
Oral Oncol; 2021 Apr; 115():105200. PubMed ID: 33610003
[TBL] [Abstract][Full Text] [Related]
7. Anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma.
Lu TZ; Zeng FJ; Hu YJ; Fang M; Zhong FY; Chen BJ; Zhang H; Guo QJ; Pan JJ; Gong XC; Huang SH; Liao ZH; Xia Y; Li JG
Cancer Med; 2023 Dec; 12(24):22091-22102. PubMed ID: 38073447
[TBL] [Abstract][Full Text] [Related]
8. Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery.
Lin C; Wu J; Ding S; Goh C; Andriani L; Lu S; Shen K; Zhu L
J Natl Compr Canc Netw; 2019 Dec; 17(12):1521-1528. PubMed ID: 31805535
[TBL] [Abstract][Full Text] [Related]
9. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
10. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
[TBL] [Abstract][Full Text] [Related]
11. Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK; Lin C; Huang SH; Chau TC; Guo QJ; O'Sullivan B; Lam KO; Chau SC; Chan SY; Tong CC; Vardhanabhuti V; Kwong DLW; So TH; Ng CY; Leung TW; Luk MY; Lee AWM; Choi HCW; Pan JJ; Lee VHF
Oral Oncol; 2022 Mar; 126():105736. PubMed ID: 35121396
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
13. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival.
Jiang R; You R; Pei XQ; Zou X; Zhang MX; Wang TM; Sun R; Luo DH; Huang PY; Chen QY; Hua YJ; Tang LQ; Guo L; Mo HY; Qian CN; Mai HQ; Hong MH; Cai HM; Chen MY
Oncotarget; 2016 Jan; 7(3):3645-57. PubMed ID: 26636646
[TBL] [Abstract][Full Text] [Related]
14. Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival.
Pan C; He N; Zhao M; Gu Y; Huang Z; Li W; Xia Y; Wu P
Med Oncol; 2011 Dec; 28(4):1349-55. PubMed ID: 20820948
[TBL] [Abstract][Full Text] [Related]
15. Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.
Sun XS; Liang YJ; Liu SL; Chen QY; Guo SS; Wen YF; Liu LT; Xie HJ; Tang QN; Li XY; Yan JJ; Tang LQ; Mai HQ
Cancer Res Treat; 2019 Oct; 51(4):1259-1268. PubMed ID: 30653745
[TBL] [Abstract][Full Text] [Related]
16. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
Chan SK; O'Sullivan B; Huang SH; Chau TC; Lam KO; Chan SY; Tong CC; Vardhanabhuti V; Kwong DL; Ng CY; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454830
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
[TBL] [Abstract][Full Text] [Related]
19. Predicted outcomes of subdividing M1-stage metastatic lung cancer based on the prognosis and the response to local consolidative therapy.
Wang F; Gao J; Ren Y; Su H; She Y; Xie D; Chen C
Ann Transl Med; 2021 Aug; 9(16):1293. PubMed ID: 34532430
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]